Holen Sie sich die Stockscreener-App
39.45
0.23%
-0.09
Handel nachbörslich:
39.51
0.06
+0.15%
Schlusskurs vom Vortag:
$39.54
Offen:
$39.42
24-Stunden-Volumen:
34,638
Relative Volume:
0.32
Marktkapitalisierung:
$549.28M
Einnahmen:
$138.20M
Nettoeinkommen (Verlust:
$5.52M
KGV:
-23.91
EPS:
-1.65
Netto-Cashflow:
$9.86M
1W Leistung:
+0.31%
1M Leistung:
+5.17%
6M Leistung:
-6.29%
1J Leistung:
+19.84%
1-Tages-Spanne:
$39.42
$39.58
1-Wochen-Bereich:
$39.12
$39.78
52-Wochen-Spanne:
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
Firmenname
Surmodics Inc
Sektor
Branche
Telefon
(952) 500-7000
Adresse
9924 W 74TH ST, EDEN PRAIRIE, MN
Vergleichen Sie SRDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
39.45 | 549.28M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-13 | Hochstufung | Needham | Hold → Buy |
| 2023-02-13 | Herabstufung | Needham | Buy → Hold |
| 2020-07-23 | Hochstufung | Needham | Hold → Buy |
| 2019-12-11 | Herabstufung | Needham | Buy → Hold |
| 2019-11-01 | Herabstufung | Lake Street | Buy → Hold |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Lake Street | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-02-21 | Bestätigt | Needham | Buy |
| 2018-05-16 | Bestätigt | Needham | Buy |
| 2018-03-01 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-02-28 | Bestätigt | Lake Street | Buy |
| 2018-02-28 | Eingeleitet | Needham | Buy |
| 2017-07-14 | Eingeleitet | Lake Street | Buy |
| 2016-11-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-05-03 | Bestätigt | Barrington Research | Outperform |
| 2015-08-06 | Bestätigt | Barrington Research | Outperform |
| 2015-03-27 | Eingeleitet | Dougherty & Company | Buy |
| 2014-02-25 | Eingeleitet | Laidlaw | Buy |
| 2013-08-01 | Hochstufung | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Surmodics Inc Aktie (SRDX) Neueste Nachrichten
Q2 Earnings Estimate for Surmodics Issued By Zacks Research - MarketBeat
Insider Sell: Timothy Arens Sells 7,009 Shares of Surmodics Inc (SRDX) - GuruFocus.com
FY2025 EPS Estimates for Surmodics Increased by Analyst - MarketBeat
SRDX (Surmodics) Cyclically Adjusted PS Ratio : 4.90 (As of Nov. 26, 2024) - GuruFocus.com
Principal Financial Group Inc. Purchases Shares of 30,696 Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Now Covered by StockNews.com - MarketBeat
SurModics Inc. Faces Legal Hurdles: Shareholder Lawsuits Threaten Merger and Financial Stability - Yahoo Finance
The Gory Details on SurModics's Double Miss - AOL
(SRDX) Long Term Investment Analysis - Stock Traders Daily
Surmodics Inc. (SRDX) reports earnings - Quartzy
Nashville InnoSurmodics adds to med-device portfolio with $39.9M acquisition of Vetex Medical - The Business Journals
Phocas Financial Corp. Invests $3.43 Million in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Coverage Initiated at StockNews.com - MarketBeat
Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down - MSN
SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Medical Device Coatings Market: Expected High CAGR with Key - openPR
Surmodics FY2026 EPS Forecast Lifted by Barrington Research - MarketBeat
Nisa Investment Advisors LLC Sells 67,336 Shares of Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Barrington Research Predicts Higher Earnings for Surmodics - MarketBeat
SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates - MSN
48,591 Shares in Surmodics, Inc. (NASDAQ:SRDX) Bought by Olympiad Research LP - MarketBeat
Needham & Company LLC Reiterates "Hold" Rating for Surmodics (NASDAQ:SRDX) - MarketBeat
Surmodics revenue jumps 19% to USD 33.2M in Q4 2024 - Medical Buyer
Surmodics (NASDAQ:SRDX) Shares Cross Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Surmodics Inc. Reports Q4 and FY 2024 Results - TipRanks
Morgan Stanley's Strategic Reduction in Surmodics Inc Holdings - GuruFocus.com
Surmodics reports Q4 EPS (13c), consensus (29c) - TipRanks
SurModics: Fiscal Q4 Earnings Snapshot - San Antonio Express-News
Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results - Business Wire
Surmodics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com
Surmodics reports high success in limb ischemia study By Investing.com - Investing.com Australia
Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System - BioSpace
Surmodics reports high success in limb ischemia study - Investing.com India
When (SRDX) Moves Investors should Listen - Stock Traders Daily
Surmodics (NASDAQ:SRDX) Now Covered by Analysts at StockNews.com - MarketBeat
Medical Coatings Market to Grow by USD 5.07 Billion from 2024-2028, Driven by Geriatric Population Growth and AI-Redefining the Market LandscapeTechnavio - Yahoo Finance Australia
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by Millennium Management LLC - MarketBeat
Surmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Surmodics, Inc. to Post FY2025 Earnings of $0.13 Per Share, Zacks Research Forecasts (NASDAQ:SRDX) - MarketBeat
AQR Capital Management LLC Reduces Holdings in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Trend Tracker for (SRDX) - Stock Traders Daily
Algert Global LLC Makes New $577,000 Investment in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.com - MarketBeat
SRDX Stock Down Despite FDA Clearance for Pounce XL System - MSN
Biocompatible Coating Market to Reach $41.4 Billion, Globally, by 2033 at 12% CAGR: Allied Market Research - GlobeNewswire Inc.
Finanzdaten der Surmodics Inc-Aktie (SRDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):